DOI:

A space for dialogue and innovation, for protocols and practicalities

Patrick W. Serruys, Editor-in-Chief

Dear Colleagues,

So much is happening worldwide that it seems hardly a moment has passed since I was welcoming you to our second year of publication, and yet another 12 months has now gone by, and here we are entering our third year. How well I know personally the rapid developments in our profession, and the demands on our professional lives which impinge on our ability to stand back and get an overview of what is going on. That is why we have attempted to create within the pages of this journal, as well as through our newly designed website and submission module called RESUMÉ, a quiet and yet vital space for discussion, for underlining experience, for reference and for results.

The influx of breaking news and papers is more than any one edition of the journal can hold. Now the website will feature some of the most important of these articles before they are published, as well as our more traditional offerings of moving images that augment the value of published articles and case reports that are exclusive to the internet. We believe we have increased the ease with which this website functions, and hope that the new possibility of online submissions will encourage many of you to submit papers.

Dialogue and innovation

The ongoing discussion between surgeons and interventionalists is crucial for the advancement of our work, in the last edition of EuroIntervention David Holmes and David Taggart gave their views on the subject, this time we will hear first from Carlos Ruiz and Philipp Bonhoeffer, and then Allan Stewart and Craig Smith with their special perspectives on valves.

We are extremely pleased to be presenting as well two first-in-man papers RESOLUTE and TRYTON. The RESOLUTE program concerns a new biocompatible polymer whose outer surface is hydrophilic leading to higher biocompatibility, featuring an interior surface that remains hydrophobic, which can increase the precision of drug release. The TRYTON study focuses on the Side-Branch stent for bifurcation lesions which uses a balloon expandable, 5 Fr compatible system delivered with a single wire, which can be used in conjunction with any existing standard stent for the main vessel. More details, and debates, in the pages that follow.

Protocols and hands-on practice

Along with our work with the EAPCI, you will find seminal articles from the EuroCTO Club and the European Bifurcation Club as they continue to develop and promote, not only the practice of their particular specialities, but also assuring the standards for European education and the qualifications necessary in practising these techniques. Within these articles you will see the current practise norms debated, the issues that remain unanswered explored, and those items that elicit consensus clearly stated.

In terms of day-to-day practice, this issue – please excuse my play on words – “focuses” on the latest developments of imaging with hands-on discussions of new and important tools for the practitioner. These take the form of a novel three-dimensional quantitative coronary angiography system and expert reviews on CTO written by Drs. Tsuchida, Dvir and Tanigawa.

This then is EuroIntervention today.

I hope you find it useful, informative, timely. Participate by joining us on our new website, being active in your local professional associations, submitting your papers to us online through our new RESUMÉ submission module and telling us what you want – and need – to see and hear.

We will do our best, in our third year of continuing to evolve towards a more interactive and vital partner in our profession, a forum that you can trust, and refer to with confidence.

Volume 3 Number 1
May 22, 2007
Volume 3 Number 1
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-D-26-00601 Jun 15, 2026
Unloading the clock: when timing meets physiology in STEMI shock
Møller J and Schrage B
free

Editorial

10.4244/EIJ-D-26-00394 Jun 15, 2026
Transcatheter edge-to-edge repair for primary mitral regurgitation: what lies ahead?
Petronio A and Mazzola M
free

Original Research

10.4244/EIJ-D-25-01308 Jun 15, 2026
Temporal trends in mitral edge-to-edge repair for primary mitral regurgitation
Koell B et al

Flashlight

10.4244/EIJ-D-25-01353 Jun 15, 2026
Transcatheter approximation of papillary muscles
Tekieli L et al
open access

Editorial

10.4244/EIJ-D-26-00479 Jun 1, 2026
Valve thrombosis or valve deterioration: what truly drives the prognosis?
Waksman R and Phichaphop A
free
Trending articles
334.8

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
202.75

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
47.45

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
42.15

State-of-the-Art

10.4244/EIJ-D-25-00896 Apr 6, 2026
Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation
Kaur G et al
free
33.05

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
27.6

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
27.6

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
19.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
X

PCR
Impact factor: 9.2
2025 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2026)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved